The UCLA Vine Street Clinic has begun enrollment in the Moderna trial. This is one of several studies seeking a vaccine for SARS-CoV-2, also known as COVID-19.
The purpose of this study is to test Moderna’s vaccine candidate (mRNA-1273) to see if it can prevent illness in people who are exposed to the SARS-CoV-2 virus in their everyday lives. This vaccine is not made from the SARS-CoV-2 virus. It is made from messenger ribonucleic acid (mRNA), a genetic code that tells cells how to make protein, which helps the body’s immune system make antibodies that can fight the virus. The vaccine cannot cause COVID-19 infection.
This Phase 3 trial is being conducted at multiple clinic sites across the U.S. with a goal of enrolling 30,000 patients. Trial participants will receive 2 injections, approximately 28 days apart, and will complete regular follow ups over the course of two years via phone calls, on-line surveys and additional in-person visits. The trial is coordinated through the newly formed COVID-19 Prevention Network. More info can be found here: https://www.coronaviruspreventionnetwork.org/ or visit our Active Research page.